| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma
|
Habringer, Stefan
|
|
|
196 |
C |
p.
|
artikel
|
| 2 |
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF V600 mutant advanced melanoma (INTERIM)
|
Dayimu, Alimu
|
|
|
196 |
C |
p.
|
artikel
|
| 3 |
Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC
|
Belderbos, R.A.
|
|
|
196 |
C |
p.
|
artikel
|
| 4 |
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
|
Wagner, Nikolaus B.
|
|
|
196 |
C |
p.
|
artikel
|
| 5 |
Clinical trials that leverage external data: Do we need more transparent protocols and statistical plans?
|
Schwartz, Daniel Evan
|
|
|
196 |
C |
p.
|
artikel
|
| 6 |
Deep learning based histological classification of adnex tumors
|
Jansen, Philipp
|
|
|
196 |
C |
p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
196 |
C |
p.
|
artikel
|
| 8 |
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
|
Li, Jian
|
|
|
196 |
C |
p.
|
artikel
|
| 9 |
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
|
Agirrezabal, Ion
|
|
|
196 |
C |
p.
|
artikel
|
| 10 |
First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
|
Janku, Filip
|
|
|
196 |
C |
p.
|
artikel
|
| 11 |
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort
|
Galvin, Angéline
|
|
|
196 |
C |
p.
|
artikel
|
| 12 |
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction
|
van Eijck, Casper W.F.
|
|
|
196 |
C |
p.
|
artikel
|
| 13 |
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma
|
de Miguel-Perez, Diego
|
|
|
196 |
C |
p.
|
artikel
|
| 14 |
Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases
|
Fakih, Marwan
|
|
|
196 |
C |
p.
|
artikel
|
| 15 |
Impact of colorectal cancer screening on survival after metachronous metastasis
|
Hamers, Patricia A.H.
|
|
|
196 |
C |
p.
|
artikel
|
| 16 |
Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study
|
Debets, Pien
|
|
|
196 |
C |
p.
|
artikel
|
| 17 |
Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization – Implications in treatment outcomes
|
Núñez, Kelley G.
|
|
|
196 |
C |
p.
|
artikel
|
| 18 |
Major cardiovascular adverse events in older adults with early-stage triple-negative breast cancer treated with adjuvant taxane + anthracycline versus taxane-based chemotherapy regimens: A SEER-medicare study
|
Roy, Savannah
|
|
|
196 |
C |
p.
|
artikel
|
| 19 |
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting
|
Saberzadeh-Ardestani, Bahar
|
|
|
196 |
C |
p.
|
artikel
|
| 20 |
Osimertinib-induced urticarial vasculitis in a patient with lung cancer: A rare cutaneous toxicity
|
Weng, Pei-Chun
|
|
|
196 |
C |
p.
|
artikel
|
| 21 |
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
|
García-Sáenz, José Angel
|
|
|
196 |
C |
p.
|
artikel
|
| 22 |
Peptide absent sequences emerging in human cancers
|
Tsiatsianis, Georgios Christos
|
|
|
196 |
C |
p.
|
artikel
|
| 23 |
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial
|
Melisi, Davide
|
|
|
196 |
C |
p.
|
artikel
|
| 24 |
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort
|
Jonasch, Eric
|
|
|
196 |
C |
p.
|
artikel
|
| 25 |
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
|
Valenza, Carmine
|
|
|
196 |
C |
p.
|
artikel
|
| 26 |
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years
|
Blay, JY
|
|
|
196 |
C |
p.
|
artikel
|
| 27 |
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY)
|
Nero, Camilla
|
|
|
196 |
C |
p.
|
artikel
|
| 28 |
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
|
Hepner, Adriana
|
|
|
196 |
C |
p.
|
artikel
|
| 29 |
Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network
|
Aristei, Cynthia
|
|
|
196 |
C |
p.
|
artikel
|
Tijdschrift beschrijving